How direct-to-patient programming can transform the prescription journey for patients and manufacturers alike. The status quo ...
Correction, Sept. 9: The list price of Zepbound has been revised from an earlier version of this article. Eli Lilly’s decision to sell its obesity drug Zepbound directly to patients for $499 per month ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results